
Corvus Pharmaceuticals
Burlingame, California, United StatesFounded 201446+ employeesCRVS
$446.7M raisedIPO· last: post ipo equity (Jan 2026)· 7 rounds
Backed by(13 investors)
OrbiMed · LeadEcoR1 Capital · LeadRock Springs Capital · Lead+9 more
Corvus is a unique environment for exceptional individuals who want to learn, contribute to an exceptional team, and make a difference in the lives of people with cancer. At Corvus, we take pride in our collaborative, community-based culture. We understand that the most successful teams are those that learn from each other and co-create in an environment that nurtures open, transparent communication.